Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Effect of Rice Bran and Cooked Navy Beans on Cholesterol Levels in Healthy Children
NCT01911390 · View on ClinicalTrials.gov ↗
Study Summary
A multidisciplinary team of clinicians and researchers will conduct a pilot feasibility study to evaluate whether dietary intake of dry bean powder or rice bran or a combination is a helpful dietary recommendation to reduce total cholesterol levels in children with identified, modifiable CVD risk factors, elevated total cholesterol and obesity. Consumption of dry bean powder and rice bran merit additional investigation to study feasibility and acceptability in children and how they influence their lipid levels or obesity.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Bean powder
- DIETARY_SUPPLEMENT Rice bran
- DIETARY_SUPPLEMENT Control arm
- DIETARY_SUPPLEMENT Bean powder and rice bran
Study Locations (2)
Colorado
- Colorado State University — Fort Collins
- Medical Center of the Rockies — Loveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2013-07 |
| Est. Completion | 2016-11 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01911390
The ClinicalTrials.gov registry entry for NCT01911390 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Poudre Valley Health System, which has 3 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Hyperlipidemias appearing as the primary indexed condition, and to 4 interventions — of which Bean powder is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT01911390 reports 2 study locations spanning 1 distinct geographic area — top geographies include Colorado. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT01911390 about?
NCT01911390 is a clinical study titled "Effect of Rice Bran and Cooked Navy Beans on Cholesterol Levels in Healthy Children". A multidisciplinary team of clinicians and researchers will conduct a pilot feasibility study to evaluate whether dietary intake of dry bean powder or rice bran or a combination is a helpful dietary recommendation to reduce total cholesterol levels in children with identified, modifiable CVD risk fa...
What is the current status of trial NCT01911390?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2013-07. Estimated completion is 2016-11.
What conditions does trial NCT01911390 study?
This clinical trial studies the following conditions: Hyperlipidemias. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT01911390?
The interventions under investigation include: Bean powder (DIETARY_SUPPLEMENT), Rice bran (DIETARY_SUPPLEMENT), Control arm (DIETARY_SUPPLEMENT), Bean powder and rice bran (DIETARY_SUPPLEMENT). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT01911390?
This trial is sponsored by Poudre Valley Health System, which has 3 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT01911390 being conducted?
This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.